NOXXON Pharma NV
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From NOXXON Pharma NV
Novartis's Jakavi joins the likes of Roche's Actemra in targeting the life-threatening immune reaction which is killing acutely ill COVID-19 patients.
Europe's biotech companies can add value by taking a global view, Scrip heard at Bio-Europe.
Pipeline Watch: Phase III Starts With Fitusiran In Hemophilia, Zoliflodacin In Gonorrhea, Opdivo Combo In RCC
Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.
The treatment landscape in renal anemia is set for major changes over the next few years as a novel class of drugs approaches the market. A new report from Biomedtracker looks at the major players battling it out in the clinic.
- Antisense, Oligonucleotides
- Large Molecule
- Other Names / Subsidiaries
- NOXXON Pharma AG